Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 30B pseudogene 1 (ANKRD30BP1) is a pseudogene in the human genome, annotated as having high sequence similarity to functional ankyrin repeat domain genes, but it does not produce a functional final protein product[2][7]. Pseudogenes are genomic sequences resembling known genes but are nonfunctional owing to disruptive mutations or lack of regulatory elements necessary for protein expression. Like most pseudogenes, ANKRD30BP1 accumulates mutations without selective pressure[7]. There is no evidence linking ANKRD30BP1 to biological processes, disease causation, or therapeutic targeting[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 30B pseudogene 1 (ANKRD30BP1).